HMP Global January 21, 2025
A recent study published in BMC Cancer developed an artificial intelligence (AI)-based model to predict survival outcomes for patients with advanced non-small cell lung cancer (NSCLC), offering a step forward in personalized medicine. The study focused on creating a robust survival prediction tool that incorporates clinical, treatment, and radiomics data, aiming to guide the selection of first-line treatment strategies in a diverse patient population.
Using a random survival forest (RSF) algorithm, researchers analyzed data from 459 patients with advanced NSCLC, split...
Today's Sponsors
Today's Sponsor